COMPARISON OF PATIENT, ONCOLOGIST, AND ONCOLOGY NURSE PREFERENCES FOR ATTRIBUTES OF DRUG THERAPY IN ADVANCED MELANOMA

被引：0
|
作者：
Liu, F. X. [1 ]
Witt, E. A. [2 ]
Ebbinghaus, S. [1 ]
Beyer, DiBonaventura G. [2 ]
Basurto, E. [2 ]
Joseph, R. W. [3 ]
机构：
[1] Merck & Co Inc, N Wales, PA USA
[2] Kantar Hlth, Princeton, NJ USA
[3] Mayo Clin, Jacksonville, FL 32224 USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PP1
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [1] ONCOLOGY NURSE PREFERENCES FOR ATTRIBUTES OF DRUG THERAPY IN ADVANCED MELANOMA.
    Liu, Frank Xiaoqing
    Witt, Edward A.
    Ebbinghaus, Scot
    Beyer, Grace DiBonaventura
    Basurto, Enrique
    Joseph, Richard
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [2] Patient and oncologist preferences for attributes of treatments in advanced melanoma: a discrete choice experiment
    Liu, Frank Xiaoqing
    Witt, Edward A.
    Ebbinghaus, Scot
    Beyer, Grace DiBonaventura
    Shinde, Reshma
    Basurto, Enrique
    Joseph, Richard W.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1389 - 1399
  • [3] Patient and Oncology Nurse Preferences for the Treatment Options in Advanced Melanoma A Discrete Choice Experiment
    Liu, Frank Xiaoqing
    Witt, Edward A.
    Ebbinghaus, Scot
    Beyer, Grace DiBonaventura
    Basurto, Enrique
    Joseph, Richard W.
    CANCER NURSING, 2019, 42 (01) : E52 - E59
  • [4] PATIENT PREFERENCES FOR TREATMENT ATTRIBUTES IN ONCOLOGY
    Rodriguez, A. M.
    Philpott, S.
    Batchelder, L.
    VALUE IN HEALTH, 2022, 25 (07) : S569 - S569
  • [5] Patient Preferences for advanced malignant Melanoma Therapy: Influence of Comordities
    Weilandt, J.
    Diehl, K.
    Schaarschmidt, M. L.
    Kiecker, F.
    Sasama, B.
    Pronk, M.
    Ohletz, J.
    Koennecke, A.
    Mueller, V.
    Utikal, J. S.
    Hillen, U.
    Harth, W.
    Peitsch, W. K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 21 - 22
  • [6] Patient preferences for clinical attributes of metastatic melanoma treatment with targeted therapy and immunotherapy
    Mansfield, Carol
    Ndife, Briana
    Chen, Joyce S.
    Gallaher, Kathleen
    Ghate, Sameer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Patient preferences for diabetes treatment attributes and drug classes
    Flood, Emuella M.
    Bell, Kelly F.
    de la Cruz, Marie C.
    Ginchereau-Sowell, France M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (02) : 261 - 268
  • [8] Patient preferences for treatment of advanced melanoma: impact of comorbidities
    Weilandt, Juliane
    Diehl, Katharina
    Schaarschmidt, Marthe-Lisa
    Kiecker, Felix
    Sasama, Bianca
    Pronk, Melanie
    Ohletz, Jan
    Koennecke, Andreas
    Mueller, Verena
    Utikal, Jochen
    Hillen, Uwe
    Harth, Wolfgang
    Peitsch, Wiebke K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (01): : 58 - 70
  • [9] Patient-Preferences for the adjuvant and palliative Therapy of advanced Malignant Melanoma: a Ciscrete Choice Experiment
    Weilandt, J.
    Diehl, K.
    Schaarschmidt, M. L.
    Kiecker, F.
    Sasama, B.
    Pronk, M.
    Ohletz, J.
    Koennecke, A.
    Mueller, V.
    Utikal, J.
    Hillen, U.
    Harth, W.
    Peitsch, W. K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 15 - 15
  • [10] Patient preferences for treatment of advanced melanoma-Impact of comorbidities
    Weilandt, J.
    Diehl, K.
    Schaarschmidt, M. L.
    Kiecker, F.
    Sasama, B.
    Pronk, M.
    Ohletz, J.
    Koennecke, A.
    Mueller, V.
    Utikal, J. S.
    Hillen, U.
    Harth, W.
    Peitsch, W. K.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E59 - E60
12345